Diabetes care and education specialists play a major role in helping people with diabetes learn about and reduce their risk for complications, especially cardiovascular disease (CVD). While many treatments and lifestyle modifications can help people with diabetes reduce risks for CVD, persistent cardiovascular risk (P-CVR) remains an issue for individuals with type 2 diabetes despite treatment with statins and effective LDL lowering. Dr. Jennifer Goldman, a diabetes care and education specialist and pharmacist for over 31 years, joins us to discuss the elevated risk for CVD in people with diabetes and a tool in the diabetes toolbox to help those with CVD and persistent CVD risk.
This podcast episode and the participation of Dr. Jennifer Goldman is sponsored by Amarin Pharma, Inc., makers of VASCEPA® (icosapent ethyl). To learn more about VASCEPA and to access the full prescribing information, visit VASCEPA.com.